Control of lysosomal-mediated cell death by the pH-dependent calcium channel RECS1
Artículo
Open/ Download
Access note
Acceso abierto
Publication date
2021Metadata
Show full item record
Cómo citar
Pihan, Philippe
Cómo citar
Control of lysosomal-mediated cell death by the pH-dependent calcium channel RECS1
Author
- Pihan, Philippe;
- Lisbona, Fernanda;
- Borgonovo, Janina Edith;
- Edwards Jorquera, Sandra Sofía;
- Nunes Hasler, Paula;
- Castillo, Karen;
- Kepp, Oliver;
- Urra, Hery;
- Saarnio, Suvi;
- Vihinen, Helena;
- Carreras Sureda, Amado;
- Forveille, Sabrina;
- Sauvat, Allan;
- De Giorgis, Daniela;
- Pupo, Amaury;
- Rodríguez, Diego A.;
- Quarato, Giovanni;
- Sagredo, Alfredo;
- Lourido Araneda, María Fernanda;
- Letai, Anthony;
- Latorre, Ramón;
- Kroemer, Guido;
- Demaurex, Nicolás;
- Jokitalo, Eija;
- Concha Nordemann, Miguel Luis Angel;
- Glavic Maurer, Alvaro Alberto;
- Green, Douglas R.;
- Hetz Flores, Claudio Andrés;
Abstract
Programmed cell death is regulated by the balance between activating and inhibitory signals. Here, we have identified RECS1 (responsive to centrifugal force and shear stress 1) [also known as TMBIM1 (transmembrane BAX inhibitor motif containing 1)] as a proapoptotic member of the TMBIM family. In contrast to other proteins of the TMBIM family, RECS1 expression induces cell death through the canonical mitochondrial apoptosis pathway. Unbiased screening indicated that RECS1 sensitizes cells to lysosomal perturbations. RECS1 localizes to lysosomes, where it regulates their acidification and calcium content, triggering lysosomal membrane permeabilization. Structural modeling and electrophysiological studies indicated that RECS1 is a pH-regulated calcium channel, an activity that is essential to trigger cell death. RECS1 also sensitizes whole animals to stress in vivo in Drosophila melanogaster and zebrafish models. Our results unveil an unanticipated function for RECS1 as a proapoptotic component of the TMBIM family that ignites cell death programs at lysosomes.
Patrocinador
Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)
CONICYT FONDECYT 3150269
1180999
1190203
1180186
11180825
15200002
1190119
3210294
1140522
3190738
1190806
PIA ACT192015
P09-015-F
ANID/FONDAP program 15150012
Takeda Pharmaceutical Company Ltd P09-015-F
FONDEF ID16I10223
D11E1007
Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT) C17S02
United States Department of Defense
Air Force Office of Scientific Research (AFOSR) FA9550-16-1-0384
Office of Naval Research N62909-16-1-2003
Nucleus Physics of Active Matter, FONDEQUIP EQM130051
Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT) PCHA/Doctorado Nacional/21120667
Ligue contre le Cancer (equipe labellisee)
French National Research Agency (ANR)
Fondation ARC pour la Recherche sur le Cancer
Region Ile-de-France
Chancelerie des universites de Paris (Legs Poix), Fondation pour la Recherche Medicale (FRM)
European Commission
European Commission Joint Research Centre
European Research Area Network on Cardiovascular Diseases (ERA-CVD, MINOTAUR)
Indexation
Artículo de publícación WoS
Quote Item
Sci. Adv. 7, eabe5469 (2021) 12 November 2021
Collections
The following license files are associated with this item: